Spero Therapeutics's total assets for Q2 2025 were $62.12M, a decrease of -20.06% from the previous quarter. SPRO total liabilities were $29.29M for the fiscal quarter, a -33.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.